Copanlisib: Novel PI3K Inhibitor for Treatment of Lymphoma.
Sign Up to like & getrecommendations! Published in 2020 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520620666200317105207
Abstract: Lymphoma refers to a specialized category of blood cancers which is characterized by lymph node enlargement, reduced body weight, prolonged tiredness and fever associated with sweats. Traditional treatment strategies involve chemotherapy, radiation therapy, targeted therapy,… read more here.
Keywords: lymphoma; treatment; copanlisib novel; novel pi3k ... See more keywords